NDC 61958-2501-01 - Biktarvy

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
61958-2501
Requested NDC
61958-2501-01
Package NDCs from labels
61958-2501-1, 61958-2501-2, 61958-2501-3, 61958-2501-5, 61958-2501-01
Manufacturer
Gilead Sciences, Inc.
Effective date
2026-09-09
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Biktarvy - Gilead Sciences, Inc.Gilead Sciences, Inc.2026-09-09HUMAN PRESCRIPTION DRUG LABEL
Biktarvy - REMEDYREPACK INC.REMEDYREPACK INC.2025-01-15HUMAN PRESCRIPTION DRUG LABEL
Biktarvy - A-S Medication SolutionsA-S Medication Solutions2024-04-30HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDCRelated label
61958-2501-1These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-1These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-1These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-1These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-1These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-2These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-2These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-2These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-2These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-2These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
61958-2501-1Biktarvy30 in 1 BOTTLE, PLASTICTABLET3024
61958-2501-2Biktarvy7 in 1 BOTTLE, PLASTICTABLET724
61958-2501-3Biktarvy30 in 1 BLISTER PACKTABLET3024
61958-2501-5Biktarvy30 in 1 BLISTER PACKTABLET3024

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
61958-2501BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE) TABLET [GILEAD SCIENCES, INC.]20Current NDC, Legacy NDC, 4 package rows20241024_664cb8f0-1f65-441b-b0d9-ba3d798be309.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
61958-2501-1EA - Each61958-25016aa39ee3-3afc-4ca2-b2e0-a3fdd44e9b2212018-03-08
61958-2501-3EA - Each61958-25013e8532ff-f9f4-48b0-b2b2-8bb1eece913a12021-06-02

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 119 · 2,378 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MISSHA M Perfect Cover BB No.25OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDEAble C&C Co., Ltd.4a24a55b-d3a4-3092-e063-6394a90a832f2026-09-11WarningsExact identifier
unii: 15FIX9V2JP
MISSHA M Perfect Cover BB No.27OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDEAble C&C Co., Ltd.4a250070-6d6b-7c20-e063-6294a90a90e42026-09-11WarningsExact identifier
unii: 15FIX9V2JP
Aveeno Kids Daily Moisture Face Mineral Sunscreen SPF 30TITANIUM DIOXIDE, ZINC OXIDEKenvue Brands LLC5b309bf0-4268-d9e4-e063-6294a90ad2d82026-09-11WarningsExact identifier
unii: 15FIX9V2JP
MISSHA M Perfect Cover BB No.29OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDEAble C&C Co., Ltd.4a25232d-0236-c107-e063-6394a90a55cf2026-09-11WarningsExact identifier
unii: 15FIX9V2JP
Aveeno Baby Daily Moisture Face Mineral Sunscreen SPF30TITANIUM DIOXIDE, ZINC OXIDEKenvue Brands LLC5b3109da-3019-73c4-e063-6394a90abb082026-09-11WarningsExact identifier
unii: 15FIX9V2JP
MISSHA M Perfect Cover BB No.31OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDEAble C&C Co., Ltd.4a254907-9ef9-e6c3-e063-6394a90a17412026-09-11WarningsExact identifier
unii: 15FIX9V2JP
MISSHA M Perfect Cover BB No.33OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDEAble C&C Co., Ltd.4a25692d-df90-322f-e063-6294a90a46222026-09-11WarningsExact identifier
unii: 15FIX9V2JP
MISSHA M Perfect Cover BB No.45OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDEAble C&C Co., Ltd.4a25912c-5b28-50f7-e063-6294a90a897d2026-09-11WarningsExact identifier
unii: 15FIX9V2JP
MISSHA M PERFECT COVER BB.13OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDEAble C&C Co., Ltd.48f73555-79ce-ae27-e063-6394a90ad41f2026-09-10WarningsExact identifier
unii: 15FIX9V2JP
MISSHA M Perfect Cover BB No.21OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDEAble C&C Co., Ltd.49fb0a82-b3ef-9784-e063-6294a90a06762026-09-10WarningsExact identifier
unii: 15FIX9V2JP
BiktarvyBICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATEGilead Sciences, Inc.664cb8f0-1f65-441b-b0d9-ba3d798be3092026-09-09Boxed warning, Warnings, Adverse reactionsExact identifier
application number: NDA210251
ndc (package): 61958-2501-5
ndc (package): 61958-2506-1
ndc (package): 61958-2501-3
ndc (package): 61958-2505-1
ndc (package): 61958-2501-2
ndc (package): 61958-2501-1
ndc (product): 61958-2506
ndc (product): 61958-2501
ndc (product): 61958-2505
ndc11 (package): 61958250101
rxcui: 2584354
rxcui: 1999673
rxcui: 2584356
rxcui: 1999667
spl id: 261dcc2a-c849-46b1-abf6-4981ed2c60bc
spl set id: 664cb8f0-1f65-441b-b0d9-ba3d798be309
unii: FWF6Q91TZO
unii: 4L5MP1Y7W7
unii: G70B4ETF4S
Stay Ageless Tinted Mineral SunscreenBROAD SPECTRUM SPF30W Aesthetics5b0f2c8f-d6fa-5e25-e063-6394a90a084d2026-09-09WarningsExact identifier
unii: 15FIX9V2JP
Leader Artificial Tears 15 mLPOLYVINYL ALCOHOL, POVIDONECardinal Health8cccc589-3a8e-baad-e053-2a95a90ab8c72026-09-09WarningsExact identifier
unii: 532B59J990
Kids Mineral Sunscreen SPF 50ZINC OXIDEHello Bello5b19f2ae-c7e5-c44c-e063-6394a90a0e682026-09-09WarningsExact identifier
unii: 15FIX9V2JP
CalamineCALAMINE, PRAMOXINE HCLUnited Natural Foods, Inc. dba UNFI0bc1a9b4-1210-4d9a-bbd2-40e9225e86ea2026-09-04Warnings, Adverse reactionsExact identifier
unii: 1K09F3G675
FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPSPOVIDONE, POLYVINYL ALCOHOL SOLUTIONHarrow Eye, LLC049e9cc9-0663-53bc-e063-6294a90a2c4f2026-09-04WarningsExact identifier
unii: 532B59J990
CalamineFERRIC OXIDE REDYour Military Exchangesaf95a66c-f063-4019-80c6-6f7dc4fee4d82026-08-28Warnings, Adverse reactionsExact identifier
unii: 1K09F3G675
BIXLENVOBICTEGRAVIR/LENACAPAVIRGilead Sciences, Inc.072a3c7e-33fb-4a87-ba21-3d8dad3f5c482026-08-27Warnings, Adverse reactionsExact identifier
unii: 4L5MP1Y7W7
d Alba UV Essence Waterfull Glow Tint Pink Correcting Face Sunscreen SPF 50HOMOSALATE, OCTINOXATE, OCTISALATE, TITANIUM DIOXIDEDalba USA Corp03e002cf-8526-4e0d-94d7-896d3714d5392026-08-27WarningsExact identifier
unii: 15FIX9V2JP
MZANK SUNSCREEN DAILY ULTIMATE PROTECTION SPF50SUNSCREEN SPF50Guangzhou Meixi Biotechnology Co., Ltd.5a0b4bd2-f6ad-35dc-e063-6294a90a8a662026-08-27WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.